Androgenic hormone profile in patients with androgenetic alopecia
- Authors: Konrakhina I.N.1, Mareeva A.N.1, Kalinina P.A.2, Abuladze M.G.1
-
Affiliations:
- State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation
- Russian Medical Academy of Postgraduate Studies, Ministry of Health of the Russian Federation
- Issue: Vol 91, No 6 (2015)
- Pages: 30-32
- Section: SHORT COMMUNICATION
- URL: https://journals.rcsi.science/0042-4609/article/view/116793
- DOI: https://doi.org/10.25208/0042-4609-2015-91-6-30-32
- ID: 116793
Cite item
Full Text
Abstract
About the authors
I. N. Konrakhina
State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation
Author for correspondence.
Email: noemail@neicon.ru
Russian Federation
A. N. Mareeva
State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation
Email: Nastasya_66@mail.ru
Russian Federation
P. A. Kalinina
Russian Medical Academy of Postgraduate Studies, Ministry of Health of the Russian Federation
Email: noemail@neicon.ru
Russian Federation
M. G. Abuladze
State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation
Email: noemail@neicon.ru
Russian Federation
References
- Hamilton J.B. Male Hormone Stimulation is a Prerequisite and Incitant in Common Baldness. J Invest Dermatol 1942; 5 (6): 473-474.
- Rathnayake D., Sinclair R. Male androgenetic alopecia. Expert Opin Pharmacother 2010; 11 (8): 1295-304.
- Urysiak-Czubatka I., Kmiec M.L., Broniarczyk-Dy+a G. Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia. Postepy dermatologii i Alergol 2014; 31 (4): 207-15.
- Trueb R.M., Lee W.S. Male Alopecia: Guide to Successful Management. Springer International Publishing AG, 2014.
- Райцева С.С. Клиническая эффективность применения препаратов NCTF 135/135HA и Эмбриобласт в профилактике и лечении андрогенной алопеции. 2013.
- Sinclair R.D. Male androgenetic alopecia (Part II) J Men’s Heal Gend 2005; 2 (1): 38-44.
- Pan H.J. et al. Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stumptailed macaques. Endocrine 1998; 9 (1): 39-43.
- Schmidt J.B., Lindmaier A., Spona J. Hormonal Parameters in Androgenetic Hair Loss in the Male. Dermatology 1991; 182 (4): 214-217.
- Cipriani R. et al. Sex hormone-binding globulin and saliva testosterone levels in men with androgenetic alopecia. Br J Dermatol 1983; 109 (3): 249-252.
- Schweikert H.U., Wilson J.D. Regulation of human hair growth by steroid hormones. I. Tester-one metabolism in isolated hairs. J Clin Endocrinol Metab 1974; 38 (5): 811-9.
- Yip L., Rufaut N., Sinclair R. Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: an update of what we now know. Australas J Dermatol 2011; 52 (2): 81-8.
- Sreekumar G.P. et al. Serum androgens and genetic linkage analysis in early onset androgenetic alopecia. J Invest Dermatol 1999; 113 (2): 277-9.
- Knussmann R., Christiansen K., Kannmacher J. Relations between sex hormone level and characters of hair and skin in healthy young men. Am J Phys Anthropol 1992; 88 (1): 59-67.
- Narad S. et al. Hormonal profile in Indian men with premature androgenetic alopecia. Int J Trichology 2013; 5 (2): 69-72.
- Starka L., Hill M., Polacek V. Hormonal profile in men with premature androgenic alopecia. Sbornik lékarsky 2000; 101 (1): 17-22.
- Sawaya M.E., Price V.H. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 1997; 109 (3): 296-300.
- Camacho F.M., Garcia-Hernandez M.J., Fernandez- Crehuet J.L. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old. Br J Dermatol 2008; 158 (5): 1121-4.
Supplementary files
